Allianz Global Investors Insights: Humanoid robotics From demonstration to deployment

At the Beijing E-Town half-marathon on 19 April 2026, Honor’s humanoid robot Lightning reportedly completed the 21.1 km course in 50 minutes and 26 seconds, faster than the current human half-marathon world record of 57 minutes and 20 seconds. The event is notable not because of its sporting dimension, but because it demonstrated visible progress in endurance, locomotion and autonomous navigation under real-world conditions.

For investors, the significance lies in capability transfer. A robot able to sustain balance, pace, directional control and operating stability over a half-marathon is also demonstrating characteristics relevant to industrial use cases such as warehouse movement, inspection and logistics support. The pace of improvement also appears striking: reporting on the same event notes that the fastest robot in the 2025 edition took around 2 hours and 40 minutes, while this year’s field expanded substantially and nearly half of the entrants reportedly ran autonomously. That suggests a development curve that may be advancing faster than many traditional industrial adoption cycles.

China’s advantage appears increasingly structural

The broader investment implication is that China’s position in humanoid robotics looks rooted not only in product development, but also in supply-chain depth and policy alignment. China’s Ministry of Industry and Information Technology set out a roadmap in 2023 calling for a preliminary innovation system in humanoid robotics by 2025, breakthroughs in key technologies, and a secure and reliable industrial and supply chain system by 2027. More recently, China also unveiled its first national standard system for humanoid robotics and embodied intelligence, reinforcing the direction of travel from experimentation toward industrial scaling.

This policy support appears to be reinforced by commercial momentum. Industry reporting indicates that Chinese firms accounted for most global humanoid robot installations in 2025, underlining the country’s early lead in commercialisation and manufacturing scale. While marketshare figures in an emerging category should still be interpreted cautiously, the broader message is consistent: China appears to be setting the early pace in the build-out of the humanoid robotics ecosystem.

Cost remains central to the thesis

Cost competitiveness may prove just as important as technical performance. Morgan Stanley’s Humanoid 100 highlights the value chain around humanoid robotics and places particular emphasis on upstream enablers rather than only finished-product manufacturers. Secondary reporting on that analysis states that a humanoid robot produced through a Chinese supply chain could carry a bill-ofmaterials cost of roughly USD 46,000, compared with around USD 131,000 using non-Chinese suppliers. If directionally correct, that differential helps explain why Chinese manufacturers may be able to iterate faster and move sooner toward commercially viable price points.

Investment implications

From a thematic investment perspective, humanoid robotics is beginning to look less like a distant concept and more like an emerging industrial stack. The relevant exposures are not limited to robot assemblers. They extend across sensors, actuators, batteries, semiconductors, industrial software, precision manufacturing and logistics automation. In that sense, the opportunity set may be broader along the enabling value chain than in a narrow group of robot OEMs alone.

The Beijing event should therefore not be viewed as a novelty headline. It offered a visible proof point that humanoid robots are improving in ways that matter for real-world industrial deployment. Combined with policy support, manufacturing scale and falling component costs, this strengthens the case for viewing humanoid robotics as a developing multi-year investment theme rather than a purely speculative technology narrative.

Want to search for or invest in related funds?

Open the WeLab Bank App and click Featured Funds to find out more! 

Investing involves risks. The information above is for reference only and does not constitute any investment advice.

Source:

Allianz Global Investors

Importance Notice 

This document is for general information only. The information or opinion herein is not to be construed as professional investment advice or any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment products or services. This document is for general evaluation only. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person or class of persons and it has not been prepared for any particular person or class of persons. The investment products or services are not equivalent to, nor should it be treated as a substitute for, time deposit, and are not protected by the Deposit Protection Scheme in Hong Kong.    

The information or opinion presented has been developed internally and/or taken from sources (including but not limited to information providers and fund houses) believed to be reliable by WeLab Bank, but WeLab Bank makes no warranties or representation as to the accuracy, correctness, reliabilities or otherwise with respect to such information or opinion, and assume no responsibility for any omissions or errors in the content of this document.  

WeLab Bank does not take responsibility for nor does WeLab Bank endorse such information or opinion. In any event, WeLab Bank shall not be liable for any loss or damage arising from the use of and/or reliance on any market information and third-party data, forecasts and/or opinions contained in the document.  

Investment involves risks. The price of an investment fund unit may go up as well as down and the investment funds may become valueless. Past performance is not indicative of future results. WeLab Bank makes no representation or warranty regarding future performance. Any forecast contained herein as to likely future movements in interest rates, foreign exchange rates or market prices or likely future events or occurrences constitutes an opinion only and is not indicative of actual future movements in interest rates, foreign exchange rates or market prices or actual future events or occurrences (as the case may be).  

You should not make any investment decision purely based on this document. Before making any investment decisions, you should consider your own financial situation, investment objectives and experiences, risk acceptance and ability to understand the nature and risks of the relevant product(s). WeLab Bank accepts no liability for any direct, special, indirect, consequential, incidental damages or other loss or damages of any kind arising from any use of or reliance on the information or opinion herein. You should seek advice from independent financial adviser if needed.